Having trouble reading this email?
View it on your browser

Alzheimer's Association. The Brains Behind Saving Yours.

Dear Friends,

Since our inception, Part the Cloud has raised over $6.4 million to support our mission to fund Alzheimer's research with the highest probability of slowing, stopping or ultimately curing Alzheimer's disease. As we look forward to next year's Part the Cloud Gala on April 30, 2016, I wanted to share with you some exciting updates on Part the Cloud's grant recipients.

Thank you all for your support as we work to accelerate critically needed research as well as raise awareness about this terrible disease. Together, we will Part the Cloud!


Michaela "Mikey" Hoag
Michaela "Mikey" Hoag
Founder, Part the Cloud

Featured Resources
Part the Cloud Website

Learn more about the PTC Grant Recipients

Learn more about Alzheimer's Association research efforts
Part the Cloud News and Updates
UCSF Clinical Research Center at Parnassus opened its doors this summer

Dr. Adam Boxer, a 2013 PTC awardee and clinical researcher at UCSF, has four active research protocols supported at the new Center focused on experimental treatments for neurodegenerative diseases, including his study supported by the Part the Cloud award. In addition, Dr. Keith Vossel, a 2013 PTC awardee, has integrated his work into this same Center to maximize recruitment of volunteers into his study. Learn more.
Featured Part the Cloud Grant Recipient – Stephen Cunnane, Ph.D., University of Sherbrooke Québec, Canada

Title: Proof of Mechanism of a New Ketogenic Supplement Using Dual Tracer PET

This Phase 1b/2a clinical trial will examine the safety and effectiveness of a novel dietary supplement as an alternative fuel source for the brain to stabilize or reverse declining memory observed in early stages of Alzheimer’s disease. The scientists will use advanced brain imaging to determine if the proposed therapy improves brain blood flow, energy use and helps preserve memory function. Learn more.
Additional Part the Cloud Awardee Updates
  • Dr. Frank Longo, a 2013 PTC awardee, was named associate director for the new NIH-funded Alzheimer's Disease Research Center at Stanford University earlier this summer. Learn More.

  • Dr. Ahmad Salehi, a 2013 PTC awardee, and collaborator, Dr. J. Wesson Ashford from the Palo Alto Institute for Research & Education, are actively recruiting for their Phase 2 study of Formoterol A and B for Alzheimer's. Learn More.

  • Dr. Giulio Pasinetti, a 2015 PTC awardee, is part of a team investigating genetic links between Alzheimer's and Type 2 Diabetes. Their work suggests there may be both biological and genetic connections for these two diseases. Learn More.

  • Dr. Tim West, a 2015 PTC awardee from C2N Diagnostics, is part of a team that partnered with AbbVie earlier this year.  Recently, C2N and AbbVie announced orphan drug status from the FDA to advance their humanized anti-tau antibody in Progressive Supranuclear Palsy (PSP). Learn More.

  • Dr. Keith Vossel, a 2013 PTC awardee, and Dr. Whitney Wharton, a 2015 PTC awardee, each received new NIH awards of over $100,000 to support work on mechanisms of network dysfunction in Alzheimer's and on mid-life vascular risk factors for Alzheimer's disease, respectively. Learn More.
  For questions, please contact info@alz.org
View your email preferences or unsubscribe.